Bionano Genomics (NASDAQ:BNGO) Trading Down 3.8% – Time to Sell?

Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) fell 3.8% during mid-day trading on Monday . The company traded as low as $2.68 and last traded at $2.79. 54,663 shares traded hands during mid-day trading, a decline of 32% from the average session volume of 80,189 shares. The stock had previously closed at $2.90.

Bionano Genomics Stock Down 3.8 %

The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.99 and a current ratio of 1.43. The company has a market cap of $7.63 million, a P/E ratio of -0.02 and a beta of 2.24. The firm’s 50-day simple moving average is $4.85 and its 200 day simple moving average is $13.14.

Institutional Trading of Bionano Genomics

A number of large investors have recently bought and sold shares of BNGO. Jane Street Group LLC bought a new stake in shares of Bionano Genomics in the fourth quarter valued at about $118,000. Geode Capital Management LLC grew its stake in shares of Bionano Genomics by 47.3% during the 3rd quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock worth $401,000 after acquiring an additional 283,639 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in shares of Bionano Genomics in the fourth quarter valued at approximately $46,000. XTX Topco Ltd acquired a new position in Bionano Genomics during the fourth quarter worth $45,000. Finally, Carret Asset Management LLC grew its position in shares of Bionano Genomics by 39.9% in the 4th quarter. Carret Asset Management LLC now owns 119,000 shares of the company’s stock valued at $34,000 after acquiring an additional 33,945 shares during the period. 11.35% of the stock is owned by institutional investors.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.